Package leaflet: Information for the user Finasteride 5 mg Film-coated Tablets Finasteride

Similar documents
PACKAGE LEAFLET: INFORMATION FOR THE USER. FINASTERIDE 1 MG FILM-COATED TABLETS (finasteride)

Elements for a public summary

Elements for a Public Summary. Overview of disease epidemiology

M0BCore Safety Profile. Pharmaceutical form(s)/strength: 5 mg SE/H/PSUR/0002/006 Date of FAR:

SUMMARY OF PRODUCT CHARACTERISTICS. AT: Finasterid Aurobindo 5 mg Filmtabletten BE: Finasteride Aurobindo Pharma 5 mg filmomhulde tabletten

Natural Hair Transplant Medical Center, Inc Dove Street, Suite #250, Newport Beach, CA Phone

PACKAGE LEAFLET: INFORMATION FOR THE USER. Lamisil 1 % cutaneous spray solution Terbinafine hydrochloride

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

Package Leaflet: Information for the patient. Sustanon 250, 250 mg/ml, solution for injection (testosterone esters)

Dutasteride 0,5 mg Teva, zachte capsules

PACKAGE LEAFLET: INFORMATION FOR THE USER. Exembol Multidose 100 mg/ml concentrate for solution for infusion. Argatroban Monohydrate

FINASTERIDE (PROPECIA, PROSCAR) SIDE EFFECT & CONSENT FORM

PHYSICIANS CIRCULAR FINASTERIDE PROSCAR. Tablet 5-Alpha Reductase Inhibitor

SUMMARY OF PRODUCT CHARACTERISTICS 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

1001 West Broadway, Vancouver, BC V6H 4B1. Topical Finasteride

Liquid Medical Oxygen Medicinal gas, cryogenic Package Leaflet: Information for the User

FINCAR Tablets (Finasteride)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Neophyr 225 ppm mol/mol medicinal gas, compressed

Compressed Medical Oxygen Medicinal gas, compressed

Package leaflet: Information for the patient. Danazol Capsules 100 mg Danazol Capsules 200 mg danazol

CSL Behring PACKAGE LEAFLET: INFORMATION FOR THE USER

PRODUCT INFORMATION TESTOVIRON DEPOT. (testosterone enanthate)

NEW ZEALAND DATA SHEET. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each film coated tablet contains 1 mg of finasteride.

Finasteride 1mg film-coated tablets (Pharmacare )

PACKAGE LEAFLET: INFORMATION FOR THE USER. Medical Oxygen/Carbon Dioxide Mixtures Oxygen, Carbon Dioxide, Medicinal gas, compressed

List of nationally authorised medicinal products

This is an English translation of the original Chinese instruction leaflet generated by Google Translate. No amendments were made.

PROPECIA Tablets Merck Sharp & Dhome

Before you use KINERET. When you must not use it. Do not use KINERET if you have. using a medicine known as tumour necrosis factor (TNF) antagonist.

Package leaflet: Information for the patient

Before you use. When you must not use it

Gynaecomastia. Benign breast conditions information provided by Breast Cancer Care

PROPECIA finasteride 1 mg tablet

PRODUCT INFORMATION PRIMOTESTON DEPOT. (testosterone enantate)

WHY IS PREVENTION IMPORTANT?

DOSAGE FORMS AND STRENGTHS

Public Assessment Report. Scientific discussion. Dutasteride Regiomedica 0.5 mg capsules, soft (dutasteride) NL/H/2861/001/DC.

Package leaflet: Information to the user. Medicinsk Lustgas Air Liquide 100%, medicinal gas, liquefied. Nitrous oxide 100% (medicinal laughing gas)

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Linezolid 600 mg Tablets WHOPAR part 6 February 2017 (Hetero Labs Limited), TB299

HIGHLIGHTS OF PRESCRIBING INFORMATION

PREPARATION AND SELF-ADMINISTRATION INSTRUCTIONS FOR PATIENTS

PREPARATION AND SELF-ADMINISTRATION INSTRUCTIONS FOR PATIENTS

Package leaflet: Information for the user Livopan 50%/50 % medicinal gas, compressed. Nitrous oxide / Oxygen

SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT 2 QUALITATIVE AND QUANTITATIVE COMPOSITION

SUMMARY OF PRODUCT CHARACTERISTICS

ARE FINASTERIDE SIDE EFFECTS PERMANENT

STAYING ON TRACK WITH CINRYZE THERAPY

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Section 1: Identification

Package leaflet: Information for the user. Medicinal Oxygen Air Liquide 100%, Medicinal gas, compressed. Oxygen 100% (O 2 )

DUPROST Capsules (Dutasteride)

Objectives: Assisting with Medication, Checking vital Signs

MATERIAL SAFETY DATA SHEET

Dutasteride Avodart Softgel Capsule

Package leaflet: Information to the user. Kalinox 50 %/50 % medicinal gas, compressed. Nitrous oxide / Oxygen

PRODUCT INFORMATION PROVIRON

PROPECIA (finasteride) Tablets, 1 mg

SAFETY DATA SHEET. Chemical Name: (5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4- azaandrost-1-ene-17-carboxamide.

Schistosomiasis / Bilharzia

The capsules are opaque, yellow, oblong soft gelatin capsules filled with an oily and yellowish liquid, without printing.

MATERIAL SAFETY DATA SHEET

PROPECIA (Finasteride) Tablets, 1 mg

Contents. Admission Assessment Clinical Care Maternity Discharge Questions Patient s Questions...

MATERIAL SAFETY DATA SHEET

Secrets of Abang Sado : Effects of testosterone therapy. Azraai Nasruddin

SUMMARY OF PRODUCT CHARACTERISTICS

FINASTERIDE- finasteride tablet, film coated Actavis Pharma, Inc

MATERIAL SAFETY DATA SHEET

Hello Printmaking Friend!

SUMMARY OF PRODUCT CHARACTERISTICS

MATERIAL SAFETY DATA SHEET

FINASTERIDE PER ALOPECIA ANDROGENETICA FEMMINILE

AMBIEN AND PAIN KILLERS

Caring for a balloon retained gastrostomy tube (Pexact or RIG tube) GI Unit Patient Information Leaflet

FIRST AID. Study Topics. At a minimum, the following topics are to be studied for the first aid exam.

SUMMARY OF PRODUCT CHARACTERISTICS. 1 NAME OF THE MEDICINAL PRODUCT Lung test gas, CO/He AGA 0.28%, 9.3% medicinal gas, compressed

Are Steroids Worth the Risk?

Health Products Regulatory Authority

Section 1: Identification. Section 2: Hazard(s) Identification

Patient Information for the: Humanitarian Device for use in the Control of Air Leaks

BEST FINASTERIDE IN INDIA

PRODUCT INFORMATION. Apo-Finasteride 1 (Finasteride Film-coated Tablets 1 mg)

1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING

1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING

Formally known as anabolic steroids or anabolic-androgenic steroids, but they are sometimes called 'roids', 'gear' or 'juice'.

UKCCA Training. Basic First Aid. Work Manual

List of nationally authorised medicinal products

TREATMENT GUIDE. Your treatment. Your questions answered.

New Zealand Data Sheet

1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING

SAFETY DATA SHEET BLUE ANTIFREEZE

SAFETY DATA SHEET Oxycodone and Acetaminophen Tablets, USP

3. PHARMACEUTICAL FORM Capsules: dull yellow in colour, opaque, oblong soft gelatin capsules with GX CE2 printed on one side in red ink.

MATERIAL SAFETY DATA SHEET

Finasteride for womens hair loss, mayo clinic

SAFETY DATA SHEET. Version: 2.0

Safety data sheet MICRO AIR Revision date : 2009/05/20 Page: 1/6

The Human Body. Everyone Needs Healthy Systems. Blood Vessels

Transcription:

Package leaflet: Information for the user Finasteride Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor, pharmacist or nurse. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any of the side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet 1. What Finasteride 5 mg Tablets is and what it is used for 2. What you need to know before you take Finasteride 5 mg Tablets 3. How to take Finasteride 5 mg Tablets 4. Possible side effects 5. How to store Finasteride 5 mg Tablets 6. Contents of the pack and other information 1. What Finasteride 5 mg Tablets is and what it is used for Finasteride belongs to the group of medicines called 5-alpha reductase inhibitors. They act by reducing the size of the prostate gland in men. Finasteride shrinks the prostate gland in men when it is swollen. Finasteride is used in the treatment and control of benign (i.e., non-cancerous) enlargement of the prostate (benign prostatic hyperplasia - BPH). The prostate gland is found underneath the bladder (but only in man). It produces the fluid found in semen. A swollen prostate gland can lead to a condition called benign prostatic hyperplaia (BPH). Finasteride causes shrinkage of the enlarged prostate, improves urinary flow and symptoms caused by BPH, and reduces the risk of you developing a sudden inability to pass urine (known as acute urinary retention) and the need for surgery. What is BPH? If you have BPH it means that your prostate gland is swollen. It can press on the tube that urine passes through, on its way out of your body. This can lead to problems such as - Feeling like you need to pass urine more often, especially at night - Feeling that you must pass urine right away - Finding it difficult to pass urine - When you pass urine the flow of urine is weak - When you pass urine the flow stops and starts - Feeling that you cannot empty your bladder completely In some men, BPH can lead to more serious problems, such as: - Urinary tract infections - A sudden inability to pass urine - The need for surgery

2. What you need to know before you take Finasteride 5 mg Tablets Do not take Finasteride 5 mg Tablets: If you are allergic to finasteride or any of the other ingredients of Finasteride 5 mg Tablets. If you are a woman (because this medicine is for men) If you are a child Do not take finasteride if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist. Warnings and precautions: Talk to your doctor or pharmacist before taking Finasteride 5 mg Tablets - If you have a large amount of residual urine in your bladder after urinating and/or severely reduced urinary flow. If this is the case, you should be closely monitored for narrowing of the urinary tract - If you have impaired liver function. The level of finasteride in your blood may be increased if so - If your sexual partner is or may potentially be pregnant, you should avoid exposing her to your semen which could contain a tiny amount of the drug. - If you have a blood test called PSA (test used to detect prostate cancer). Tell your doctor that you are taking finasteride. Finasteride can affect the blood levels of the substance being tested, PSA. Children Finasteride should not be used in children. Other medicines and Finasteride 5mg Tablets: Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Finasteride does not usually interfere with other medicines. No significant drug interactions have been identified. Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. Taking Finasteride 5 mg Tablets with food and drink: Finasteride can be taken with or without food. Pregnancy, breast-feeding and fertility: Finasteride 5 mg Tablets are only intended for men. Finasteride should not be taken by women. Women who are or may potentially be pregnant should not handle Finasteride 5 mg Tablets especially if broken or crushed. If finasteride is absorbed through the skin or taken by mouth by women pregnant with a male foetus, the child may be born with malformed genital organs. If a women who is pregnant comes into contact with crushed or broken Finasteride tablets, speak to you doctor. When the patient s sexual partner is or may become pregnant, the patient should either avoid exposure of his partner to semen (e.g. by use of a condom) or discontinue treatment with finasteride. Driving and using machines: There is no information to suggest that Finasteride affects the ability to drive and use machines. Important information about some of the ingredients of Finasteride 5 mg Tablets: This medicinal product contains lactose. If you have been told by your doctor that you have intolerance to some sugars contact your doctor before taking this medicinal product.

3. How to take Finasteride 5 mg Tablets Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. The recommended dose is one tablet daily (equivalent to 5 mg finasteride). The film-coated tablets can either be taken on an empty stomach or with a meal. This medicine should be taken by mouth, swallowed whole and should not be divided or crushed. Your doctor may prescribe finasteride along with another medicine (called doxazosin) to help control your BPH. Although early improvement may be seen, treatment for at least six months may be necessary to assess whether a beneficial response has been achieved. Your doctor will tell you how long you should continue to take Finasteride 5 mg Tablets. Do not interrupt treatment early or the symptoms may come back. Patients with impaired liver function There is no experience of the use of Finasteride in patients with impaired liver function (see also Take special care with Finasteride 5 mg Tablets ). Patients with impaired kidney function No dosage adjustment is required. The use of Finasteride in patients who have to undergo haemodialysis has not been investigated yet. Elderly patients No dosage adjustment is required. Please speak to your doctor or pharmacist if you feel that the effects of Finasteride 5 mg Tablets is too strong or too weak. If you take more Finasteride 5 mg Tablets than you should: If you have taken more tablets than you were told to, or if someone else has taken any tablets, contact accident and emergency department of your nearest hospital. Take any left over tablets or empty box with you for easier identification. If you forget to take Finasteride 5 mg Tablets: If you forget to take a dose of Finasteride 5 mg Tablets, you can take it as soon as you remember unless it is time for the next dose, in which case you should continue with your medication as prescribed. Do not take a double dose to make up for a forgotten dose. If you stop taking Finasteride 5 mg Tablets: Your condition may show an early improvement after taking Finasteride. However, it may take at least six months for the full effect to develop. It is important to keep taking Finasteride for as long as your doctor tells you, even if you do not feel any benefit straight away. If you have any further questions on the use of this medicine, ask your doctor or pharmacist. 4. Possible side effects

Like all medicines, Finasteride 5 mg Tablets can cause side effects, although not everybody gets them. Stop taking finasteride and immediately contact a doctor if you experience any of the following symptoms (angioedema): swelling of face, tongue or throat difficulty swallowing hives and breathing difficulties The most common side effects are impotence and decreased sexual drive. These effects normally occur at the start of the treatment but do not usually last long in the majority of patients if treatment continues. Common: (may affect up to 1 in 10 people) You may have problems with ejaculation, for example a decrease in the amount of semen released during sex. This decrease in the amount of semen does not appear to affect normal sexual function. You may be unable to have an erection (impotence) You may have less desire to have sex Uncommon: (may affect up to 1 in 100 people) rash Problems with ejaculation that may continue after stopping the medication Breast swelling or tenderness Unknown: pruritus, urticaria palpitations (feeling your heartbeat) Swelling of face, lips, tongue or throat, difficulty swallowing and breathing difficulties (angioedema) changes in the way your liver is working, which can be shown by a blood test pain in your testicles an inability to obtain an erection which may continue after stopping the medication male infertility and/or poor seminal quality of semen. Improvement in the quality of the semen has been reported after stopping medication depression decrease in sex drive that may continue after stopping the medication You should promptly report to your doctor any changes in your breast tissue such as lumps, pain, enlargement or nipple discharge as these may be signs of a serious condition, such as breast cancer. Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. By reporting side effects you can help provide more information on the safety of this medicine. For UK - You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard 5. How to store Finasteride 5 mg Tablets Keep out of the sight and reach of children. This medicinal product does not require any special storage conditions.

Do not use Finasteride 5 mg Tablets after the expiry date, which is stated on the label after Exp. The expiry date refers to the last day of that month. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment. 6. Contents of the pack and other information What Finasteride 5 mg Tablets contain: The active substance is finasteride. One film-coated tablet contains 5 mg of finasteride. The other ingredients are Tablet core- lactose monohydrate, cellulose microcrystalline (E460), starch pregelatinized (maize), sodium starch glycolate (type-a), lauroyl macrogolglycerides, and magnesium stearate (E572). Film coating- Hypromellose (E464), titanium dioxide (E 171), indigo carmine (E132), macrogol 6000 What Finasteride 5 mg Tablets look like and content of the pack: Film-coated Tablet. Finasteride 5 mg Tablets are blue, round, biconvex, film-coated tablets, marked F5 on one side and plain on other side Finasteride 5 mg Tablets are packed in opaque white PVC/PVdC Alu blisters in pack of 7, 10, 14, 15, 20, 28, 30, 50, 56, 60, 84, 90, 98, 100 or 120 tablets. Not all packs may be marketed. Marketing Authorisation Holder Accord Healthcare Limited, Sage House, 319 Pinner Road, North Harrow, Middlesex HA1 4HF, UK. Manufacturer Accord Healthcare Limited, Sage House, 319 Pinner Road, North Harrow, Middlesex HA1 4HF, UK. Laboratorios Normon S.A.,Ronda de Valdecarrizo 6, 28760 Tres Cantos, Madrid, Spain This medicinal product is authorized in the Member States of the EEA under the following names: Name of the member state Estonia France Ireland Italy Latvia Malta Spain The Netherlands UK Bulgaria Cyprus Lithuania Poland Sweden Name of the medicinal product Finasteride Accord 5 mg õhukese polümeerikattega tabletid Finasteride Accord 5 mg comprimé pelliculé Finasteride AHCL 5 mg compresse rivestite con film Finasteride Accord 5 mg apvalkotās tabletes Finasterida Norman 5 mg comprimidos recubiertos con película EFG Finasteride Accord 5 mg Filmomhulde Tabletten Finasteride Accord 5 mg Film-coated Tablets Finasteride Accord 5 mg επικαλυμμένα με λεπτό υμένιο δισκία Finasteride Accord 5 mg plevele dengtos tabletės Finahit, 5 mg, tabletki powlekane Finasteride Accord 5 mg filmdragerade tabletter

Slovakia Finasteride Accord 5 mg Filmom obalené tablety This leaflet was last revised in 08/2016.